As COVID-19 continues to mutate and spread across the globe, research into how hyperbaric therapy can help has been taking off. While many studies are still in the process of being conducted, we are getting more and more insight into how hyperbaric therapy may prevent some patients from being ventilated, treat the lung inflammation caused by the virus and even treat the long-term chronic effects being dubbed “Long Hauler’s Syndrome.”
Most of our clients treating Long Hauler’s symptoms such as fatigue, brain fog, and moderate to severe pain has reported significant improvements once starting hyperbaric therapy.
Posted below are just a few of the recent published research and case studies done thus far. Please see our COVID-19 page to view even more.
Hypoxemia Severe COVID 2021 Preventing Ventilator COVID May 2020 COVID and ARDS May 2020